Pathway Capital Management, LP

SEC CIK: 0001037353
Latest filing: Aug 3, 2026

SEC filings (opens in a new tab)

MIRM holding history

Mirum Pharmaceuticals, Inc. in every 13F filed by Pathway Capital Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MIRM overview All 13F holders of MIRM Full Q2 2026 holdings

Shares (Q1 2024): 0; Sold out in Q1 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2023

Holdings of MIRM by Pathway Capital Management, LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2024	0	$0	0.0%	−190,286−100.0%	Sold out	Holders
Q4 2023	190,286	$5.62M	6.3%	+190,286	New	Holders
Q3 2023	0	$0	0.0%	−24,784−100.0%	Sold out	Holders
Q2 2023	24,784	$641.2K	1.1%	+24,784	New	Holders